Canton Strategic Holdings (CNTN) Change in Account Payables (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Change in Account Payables of -$687963.0 for Q1 2026, down 303.3% on a QoQ basis from $338404.0 in Q4 2025, and down 1191.95% year-over-year from $63003.0 in Q1 2025.
Canton Strategic Holdings (CNTN) Change in Account Payables (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$687963.0 for Q1 2026.
- Quarterly Change in Account Payables fell 1191.95% year-over-year to -$687963.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$528489.0 (down 431.5% YoY) and the FY2025 annual result came in at $222477.0, up 22.86% from the prior year.
- Change in Account Payables was -$687963.0 for Q1 2026 at Canton Strategic Holdings, down from $338404.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $466532.0 in Q2 2023 and bottomed at -$687963.0 in Q1 2026.
- A 5-year average of -$27735.0 and a median of -$1720.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 612.21% — and 2025, when it plunged 1363.97%.
- Canton Strategic Holdings' Change in Account Payables stood at $417667.0 in 2022, then sank by 155.1% to -$230118.0 in 2023, then surged by 232.9% to $305827.0 in 2024, then climbed by 10.65% to $338404.0 in 2025, then plunged by 303.3% to -$687963.0 in 2026.
- Business Quant data shows CNTN's Change in Account Payables at -$687963.0 in Q1 2026, $338404.0 in Q4 2025, and -$111356.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | -687,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -687,963.00 |
| Mar 31, 2026 | -687,963.00 |
| Dec 31, 2025 | 338,404.00 |
| Dec 31, 2025 | 338,404.00 |
| Sep 30, 2025 | -111,356.00 |
| Sep 30, 2025 | -111,356.00 |
| Jun 30, 2025 | -67,574.00 |
| Jun 30, 2025 | -67,574.00 |
| Mar 31, 2025 | 63,003.00 |
| Mar 31, 2025 | 63,003.00 |
| Dec 31, 2024 | 305,827.00 |
| Dec 31, 2024 | 305,827.00 |
| Sep 30, 2024 | 8,810.00 |
| Sep 30, 2024 | 8,810.00 |
| Jun 30, 2024 | -218,215.00 |
| Jun 30, 2024 | -218,215.00 |
| Mar 31, 2024 | 84,667.00 |
| Mar 31, 2024 | 84,667.00 |
| Dec 31, 2023 | -230,118.00 |
| Dec 31, 2023 | -230,118.00 |